Effects of continuously administered murine interleukin-1 alpha: tolerance development and granuloma formation
Authors:
- 1 September 1989
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 57 (9) , 2742-2750
Abstract
Continuous infusion of murine recombinant interleukin-1 alpha (rIL-1 alpha) into rats by using intraperitoneally implanted osmotic pumps led to marked decreases in body weight, liver enzymes (serum glutamic oxalacetic transaminase, serum glutamic pyruvic transaminase, and sorbitol dehydrogenase), appetite, and mobility and increases in drinking, blood urea nitrogen, and total peripheral blood leukocytes within 3 days. Granuloma formation was found in the local area of rIL-1 alpha release. As early as day 3, a focal infiltrate of polymorphonuclear leukocytes, mononuclear leukocytes, and plasma cells filled the area; by day 6, extensive fibrosis was found. A loss of rIL-1 alpha-induced changes, with the exception of granuloma formation, occurred by day 10. A marked decrease in the response to rIL-1 alpha was also observed when animals were challenged by implantation of new pumps containing rIL-1 alpha, with monitoring of body weight, or by subcutaneous injection of rIL-1 alpha, with monitoring of serum colony-stimulating factor production. We propose that, even in the continuous presence of interleukin-1, replacement of the acute responses to interleukin-1 by restoration of more normal physiology may be advantageous upon acquisition of specific immunity.Keywords
This publication has 40 references indexed in Scilit:
- Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AAScience, 1989
- Enhanced antibacterial resistance in neutropenic mice treated with human recombinant interleukin-1 betaInflammation Research, 1988
- Augmented interleukin‐1 production and hla–dr expression in the synovium of rheumatoid arthritis patientsArthritis & Rheumatism, 1988
- Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.Journal of Experimental Medicine, 1988
- Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1Nature, 1986
- In vivo inflammatory activity of epidermal cell-derived thymocyte activating factor and recombinant interleukin 1 in the mouse.Journal of Clinical Investigation, 1986
- InterleukinsAnnual Review of Medicine, 1986
- Interleukin-1 and the Pathogenesis of the Acute-Phase ResponseNew England Journal of Medicine, 1984
- Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics.Journal of Clinical Investigation, 1984
- THE GROWTH OF MOUSE BONE MARROW CELLS IN VITROImmunology & Cell Biology, 1966